KemPharm Inc

PROVEN MEDICINES ... SAFER THERAPIES

News/events

Press Releases

6/23/2010KemPharm, Inc. Appoints Todd Johnson, Ph.D. as Chief Commercial Officer
5/18/2010KemPharm, Inc. Announces Entering Into an Exclusive Supply Agreement With Johnson Matthey Inc. for KP201
1/11/2010KemPharm, Inc. Announces Positive Results from Phase 1 Trial of KP106 for ADHD
10/22/2009KemPharm, Inc. Announces Initiation of Phase 1 Trial of KP106 for ADHD
9/16/2009KemPharm, Inc. Expands Prodrug Pipeline with Candidate for Treatment of Pain and Closes Series B Financing

KemPharm News

4/6/2010The Technology Association of Iowa (TAI) Announces the 2010 Prometheus Award Winners
11/11/2009KemPharm's Vice President of Corporate Affairs honored with Iowa's Women of Innovation Award
9/9/2009DeWaay Backs Consumer Health Advisers From Debut VC Fund
8/15/2009DeWaay launches $10 million venture fund
1/21/2009I-Bank Taps Debut Fund For KemPharm
11/3/2008Investing outside the box

Recent/Upcoming Events

May 3-6, 2010BIO International Convention
May 25-27, 2010C21 BioVentures™
September 15-17, 2010BioPharm America™ 2010